Insmed Inc (NASDAQ:INSM)
| 10.90 Data as of May 17 |  +0.34 / +3.22%Today’s Change | 2.69 Today|||52-Week Range 11.25 | +62.93% Year-to-Date |
Latest INSM News | Press Releases
| Requiem for the Bears May 17 / TheStreet.com | Back to the Future? May 15 / TheStreet.com |
| Digging for New Buys May 17 / TheStreet.com | What's On My Radar May 15 / TheStreet.com |
| Sailing on a Sea of Liquidity May 15 / TheStreet.com |
Today’s Trading
| Previous close | 10.56 |
| Today’s open | 10.61 |
| Day’s range | 10.18 - 10.97 |
| Volume | 440,262 |
| Average volume (3 months) | 223,651 |
| Market cap | $346.6M |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +47.12% |
| Earnings growth (this year) | +9.94% |
| Earnings growth (next 5 years) | +20.00% |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 2.84 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| XOMAXOMA Corp | +0.01 | +0.24% |
| LCILannett Company Inc | +0.16 | +1.32% |
| GTXIGTX Inc | +0.11 | +1.98% |
| TXMDTherapeuticsMD Inc | -0.19 | -6.42% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$41.4M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director William H. Lewis, MBA |
Chief Financial & Accounting Officer Andrew T. Drechsler, CPA |
Corporate headquarters Monmouth Junction, New Jersey |
Forecasts
